BiomeSense
Company

Last deal

$6.2M

Amount

Venture - Series Unknown

Stage

19.12.2023

Date

11

all rounds

$9.6M

Total amount

General

About Company
BiomeSense is developing technology for at-home monitoring of the human microbiome, with the goal of transforming precision medicine.

Industry

Sector :

Subsector :

founded date

01.01.2018

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Their GutLab smart bathroom system, combined with the MetaBiome analytics platform, provides an end-to-end solution for continuous monitoring and analysis of the gut microbiome. This technology allows for real-time tracking of microbiome changes and their correlation with clinical outcomes, providing unprecedented insight into the microbiome's role in health. BiomeSense is also revolutionizing human microbiome research by providing novel tools for tracking, analyzing, and storing daily microbiome profiles of clinical trial participants, providing vastly more data than current tools at a fraction of the cost.
Contacts

Phone number

Social url